• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感和冠状病毒病期间的超额死亡人数和严重急性呼吸综合征冠状病毒 2 的感染病死率,荷兰。

Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.

出版信息

Emerg Infect Dis. 2021 Feb;27(2):411-420. doi: 10.3201/eid2702.202999. Epub 2021 Jan 4.

DOI:10.3201/eid2702.202999
PMID:33395381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853586/
Abstract

Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previous influenza epidemics. Excess deaths per influenza epidemic averaged 4,000. The estimated 9,554 excess deaths (41% in excess) during the COVID-19 epidemic weeks 12-19 of 2020 appeared comparable to the 9,373 excess deaths (18%) during the severe influenza epidemic of 2017-18. However, these deaths occurred in a shorter time, had a higher peak, and were mitigated by nonpharmaceutical control measures. Excess deaths were 1.8-fold higher than reported laboratory-confirmed COVID-19 deaths (5,449). Based on excess deaths and preliminary results from seroepidemiologic studies, we estimated the infection-fatality rate to be 1%. Monitoring of excess deaths is crucial for timely estimates of disease burden for influenza and COVID-19. Our data complement laboratory-confirmed COVID-19 death reports and enable comparisons between epidemics.

摘要

自 2009 年流感大流行以来,荷兰一直使用每周死亡监测系统来估计超出预期的死亡人数。我们报告了当前冠状病毒病(COVID-19)流行期间和之前 10 次流感流行期间的超额死亡估计数。每次流感流行的超额死亡人数平均为 4000 人。在 2020 年 COVID-19 流行的第 12-19 周,估计有 9554 例超额死亡(超额死亡 41%),与 2017-18 年严重流感流行期间的 9373 例超额死亡(18%)相当。然而,这些死亡发生的时间更短,峰值更高,并且通过非药物控制措施得到缓解。超额死亡是报告的实验室确诊 COVID-19 死亡人数(5449 例)的 1.8 倍。根据超额死亡和血清流行病学研究的初步结果,我们估计感染死亡率为 1%。监测超额死亡对于及时估计流感和 COVID-19 的疾病负担至关重要。我们的数据补充了实验室确诊 COVID-19 死亡报告,并使我们能够对不同的流行进行比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/f53352e01518/20-2999-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/683e7a4966f9/20-2999-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/e909b3e03c85/20-2999-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/f53352e01518/20-2999-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/683e7a4966f9/20-2999-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/e909b3e03c85/20-2999-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c611/7853586/f53352e01518/20-2999-F3.jpg

相似文献

1
Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.流感和冠状病毒病期间的超额死亡人数和严重急性呼吸综合征冠状病毒 2 的感染病死率,荷兰。
Emerg Infect Dis. 2021 Feb;27(2):411-420. doi: 10.3201/eid2702.202999. Epub 2021 Jan 4.
2
Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.荷兰 2017/2018 年流感流行期间智障人士的死亡率:对 COVID-19 大流行的潜在影响。
J Intellect Disabil Res. 2020 Jul;64(7):482-488. doi: 10.1111/jir.12739. Epub 2020 May 26.
3
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.西班牙社区居住人群中 SARS-CoV-2 的感染病死率:全国血清流行病学研究。
BMJ. 2020 Nov 27;371:m4509. doi: 10.1136/bmj.m4509.
4
Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?监测欧洲 COVID-19 死亡率的影响:从 2009 年甲型 H1N1p 流感死亡率研究中可以学到什么?
Int J Infect Dis. 2021 Jan;102:115-117. doi: 10.1016/j.ijid.2020.10.037. Epub 2020 Oct 16.
5
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.南非豪登省估计的 SARS-CoV-2 感染率和病死率:一项基于人群的血清流行病学调查。
Int J Epidemiol. 2022 May 9;51(2):404-417. doi: 10.1093/ije/dyab217.
6
Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.重新评估印度德里 COVID-19 疫情前 6 个月的报告死亡人数和估计感染攻击率。
Emerg Infect Dis. 2022 Apr;28(4):759-766. doi: 10.3201/eid2804.210879. Epub 2022 Feb 25.
7
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020.估算 2020 年 3 月至 5 月美国 COVID-19 大流行期间的超额死亡人数。
JAMA Intern Med. 2020 Oct 1;180(10):1336-1344. doi: 10.1001/jamainternmed.2020.3391.
8
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
9
Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 2020.2020 年 1 月至 5 月日本冠状病毒病大流行期间的全因超额死亡。
Emerg Infect Dis. 2021 Mar;27(3):789-795. doi: 10.3201/eid2703.203925.
10
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.比较 SARS-CoV-2 与 SARS-CoV 和流感大流行。
Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3.

引用本文的文献

1
Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines.利用新一代流感疫苗在血凝素存在的情况下增强神经氨酸酶免疫力。
NPJ Vaccines. 2024 Nov 19;9(1):228. doi: 10.1038/s41541-024-01011-x.
2
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.2020 年 2 月至 2021 年 6 月期间荷兰不同年龄段严重急性呼吸综合征冠状病毒 2 型的严重程度。
Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug.
3
Inference of age-dependent case-fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands.

本文引用的文献

1
COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.2019冠状病毒病——探究长期病症类型和共病程度对寿命损失年数的影响:一项建模研究
Wellcome Open Res. 2021 Mar 1;5:75. doi: 10.12688/wellcomeopenres.15849.3. eCollection 2020.
2
The association between influenza infections in primary care and intensive care admissions for severe acute respiratory infection (SARI): A modelling approach.初级保健中流感感染与重症急性呼吸道感染(SARI)重症监护入院之间的关联:一种建模方法。
Influenza Other Respir Viruses. 2020 Sep;14(5):575-586. doi: 10.1111/irv.12759. Epub 2020 Jun 12.
3
利用荷兰的数据推断季节性流感病毒亚型 A(H3N2)和 A(H1N1)pdm09 及 B 谱系的年龄相关病死率比。
Influenza Other Respir Viruses. 2023 Jun 19;17(6):e13146. doi: 10.1111/irv.13146. eCollection 2023 Jun.
4
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life.有症状的 SARS-CoV-2 发作和与健康相关的生活质量。
Appl Health Econ Health Policy. 2023 Sep;21(5):761-771. doi: 10.1007/s40258-023-00810-y. Epub 2023 May 27.
5
Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022.2020 年 3 月 1 日至 2022 年 1 月 1 日期间美国 COVID-19 大流行的直接和间接死亡影响。
Elife. 2023 Feb 22;12:e77562. doi: 10.7554/eLife.77562.
6
Influenza A(H1N1)pdm09 Virus Alters Expression of Endothelial Factors in Pulmonary Vascular Endothelium in Rats.甲型 H1N1 流感病毒改变了大鼠肺血管内皮细胞中内皮细胞因子的表达。
Viruses. 2022 Nov 14;14(11):2518. doi: 10.3390/v14112518.
7
Comparing antibiotic prescriptions in primary care between SARS-CoV-2 and influenza: a retrospective observational study.比较严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)与流感在初级保健中的抗生素处方:一项回顾性观察研究。
BJGP Open. 2022 Dec 20;6(4). doi: 10.3399/BJGPO.2022.0049. Print 2022 Dec.
8
The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.个体隔离的负担:日本因 COVID-19 与其他类流感疾病而隔离的比较。
Epidemiol Infect. 2021 Dec 10;150:e5. doi: 10.1017/S0950268821002569.
9
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients.长新冠对日本新冠患者健康相关生活质量的影响。
Health Qual Life Outcomes. 2022 Aug 19;20(1):125. doi: 10.1186/s12955-022-02033-6.
10
Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design.2020 年日本 COVID-19 爆发期间的死亡率降低:两阶段中断时间序列设计。
Int J Epidemiol. 2022 Feb 18;51(1):75-84. doi: 10.1093/ije/dyab216.
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.
4
The effect of large-scale anti-contagion policies on the COVID-19 pandemic.大规模防疫政策对 COVID-19 大流行的影响。
Nature. 2020 Aug;584(7820):262-267. doi: 10.1038/s41586-020-2404-8. Epub 2020 Jun 8.
5
Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.2020 年 2 月 1 日至 4 月 18 日,按性别和年龄划分的冠状病毒病(COVID-19)疫情死亡率影响:快速死亡率监测系统,意大利。
Euro Surveill. 2020 May;25(19). doi: 10.2807/1560-7917.ES.2020.25.19.2000620.
6
Assessment of Deaths From COVID-19 and From Seasonal Influenza.对新冠病毒肺炎死亡病例和季节性流感死亡病例的评估。
JAMA Intern Med. 2020 Aug 1;180(8):1045-1046. doi: 10.1001/jamainternmed.2020.2306.
7
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
8
COVID-19: a need for real-time monitoring of weekly excess deaths.2019冠状病毒病:需要对每周超额死亡进行实时监测。
Lancet. 2020 May 2;395(10234):e81. doi: 10.1016/S0140-6736(20)30933-8. Epub 2020 Apr 22.
9
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.非药物干预措施对 2019 年冠状病毒病和流感在香港的影响评估:一项观察性研究。
Lancet Public Health. 2020 May;5(5):e279-e288. doi: 10.1016/S2468-2667(20)30090-6. Epub 2020 Apr 17.
10
European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?2017/18 年度欧洲全因超额死亡和流感相关死亡:是否应重新考虑乙型流感的负担?
Clin Microbiol Infect. 2019 Oct;25(10):1266-1276. doi: 10.1016/j.cmi.2019.02.011. Epub 2019 Feb 18.